Healio Ocular Surgery News: The IOL that Forgives

Blog article by John A. Hovanesian, MD, FACS
April 18, 2022

Dr. Hovanesian reported on his experience implanting the first AccuraSee™ intraocular pseudophakic contact lens to improve near vision in patients with macular degeneration.

“This is a fascinating invention from Kevin J. Cady, an eye care industry veteran who devised a small implant that rests on top of and couples with an existing posterior chamber IOL, altering its focus. The concept is loaded with promise.”

“The AccuraSee™ intraocular pseudophakic contact lens (IOPCL, OnPoint Vision) is part of a first-in-human investigational device exemption study. “

“The IOPCL’s possible uses, though, are what make it exciting because they go well beyond dry AMD. Future iterations of this IOL could incorporate lower power sphere cylinder to correct residual refractive error.”

“Other designs could address higher-order aberrations or perhaps unwanted visual side effects from multifocal lenses as well as a multifocal platform that is fully reversible.

“Best of all, early evaluation of the patients shows no measurable loss of best corrected distance visual acuity and a significant improvement in near, as is common when a high add is placed in these patients.”

Read entire blog post here.

View PDF of Blog Article

President & CEO

Kevin Cady is the CEO and Founder of OnPoint Vision™, a refractive company that designs, develops & manufactures intraocular lens implants, most specifically the AccuraSee™ Intraocular Pseudophakic Contact Lens (AKA: CadyLens) designed to fine-tune the refractive error of the pseudophakic eye as well as deliver vision recovery for patients who have experienced a decline in vision due to age-related retinal pathologies.  Prior to forming OnPoint Vision™, Mr. Cady joined Refocus Group in 2015 as Vice President of Marketing & Business Development. From 2011 to 2014, Mr. Cady was the Regional Business Director for WaveTec Vision Systems, where he was responsible for the marketplace expansion of the Optiwave Refractive Analysis (ORA) system to ophthalmic surgeons. Prior to joining WaveTec Vision Systems, Mr. Cady was the Area Vice President of Sales for Bausch Lomb Surgical, after the company acquired Eyeonics. Mr. Cady has over 30 years in the ophthalmic industry theatre with extensive knowledge and experience in both the development of ophthalmic pharmacologic agents and medical device product line.

Mr. Cady has a Bachelor of Science Degree in Economics from Illinois State University. He is credentialed with over 35 patents worldwide with the  invention of the CadyLens, an Intraocular Pseudophakic Contact Lens (IOPCL) as well as related surgical instruments and medical devices.